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INTRODUCTION
The number of maintenance hemodialysis patients continues to
increase and has become a major problem worldwide. Initiation of
hemodialysis not only significantly decreases the patient’s quality
of life (1) but also increases national medical expenditure. One of
the major factors contributing to high mortality in maintenance
hemodialysis patients is malnutrition (2-4). Approximately 18%

75% maintenance dialysis patients show evidence of malnutrition,
muscle wasting, body fat loss, and inflammation(5, 6).
Various terms, such as uremic malnutrition, protein

energy
malnutrition, malnutrition

inflammation

atherosclerosis syndrome,
and malnutrition

inflammation complex syndrome, have been
used for malnutrition in patients with renal disease, resulting in
some confusion (7). Therefore, the International Society of Renal
Nutrition andMetabolism (ISRNM) proposed the term “protein

energy wasting (PEW)”, which refers to the multiple metabolic and
nutritional alterations occurring in renal disease patients, and es-
tablished diagnostic criteria for PEW (7, 8).
Serum transthyretin (TTR), also known as prealbumin, is an
acute-phase protein. The Nutritional Care Consensus Group rec-
ommended the evaluation of TTR levels in hospitalized patients
with malnutrition risk, such as elderly patients (9). Serum TTR
levels are regarded as a reliable indicator for evaluating nutritional
states and the effect of nutritional intervention in maintenance
hemodialysis patients ; in addition, the TTR level is one of the PEW
diagnostic criteria (3, 10-12). Several studies report that serum
TTR levels correlate well with survival of maintenance hemodialysis
patients and provide prognostic value independent of serum albu-
min levels and other established predictors of mortality in this
population (10, 13, 14). However, we recently reported that ‘‘de-
creased muscle mass’’ and ‘‘unintentional low dietary energy in-
take’’ were the significant differences between PEW and non-PEW
patients, classified according to PEW diagnostic criteria, rather
than ‘‘serum TTR of30 mg/dL’’ (15). This suggested that serum
TTR levels did not affect PEW, or malnutrition status, which is
contrary to the widespread belief that the correlation between
serum TTR levels and survival is related to the nutritional state,
which is reflected in serum TTR levels.
Hence, we speculate that factors other than nutritional status
influence the correlation between serum TTR levels and survival.
In this study, we investigated factors related with the serum TTR
levels of maintenance hemodialysis patients.
PATIENTS AND METHODS
Subjects
All outpatients receiving maintenance hemodialysis at Iga City
General Hospital for at least 6 months, and without clinical evi-
dence of edema, ascites, inflammatory diseases, or known malig-
nancies, were included in the study. Patients were dialyzed for
10

14 h/week using bicarbonate buffer. The clinical records of
each patient were thoroughly reviewed by the collaborating physi-
cian. This study was approved by the ethical committee of Iga City
General Hospital, and informed consent was obtained from all
patients.
ORIGINAL
Body fat mass is correlated with serum transthyretin levels in
maintenance hemodialysis patients
Sayaka Matsuura1, Yumiko Shirai2, Miyu Kubo1,3, Chisako Nayama1,3, Masami Okitsu1,3, Yuu Oiwa1,3,
Sonoko Yasui1,3, Yoshiko Suzuki1,3, Tomohiro Murata4,5, Eiji Ishikawa4,5, Chikao Miki5,6, and Yasuhiro Hamada1,3,5*
1Department of Therapeutic Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan 2Department of
Nutrition, Iga City General Hospital, Mie, Japan 3Department of Nutrition, Tokushima University Hospital, Tokushima, Japan 4Department of
Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan 5Dialysis Center, Iga City General Hospital, Mie,
Japan 6Department of Surgery, Iga City General Hospital, Mie, Japan
Abstract : Serum transthyretin (TTR), also known as prealbumin, is a reliable nutritional indicator and an inde-
pendent prognostic factor for maintenance hemodialysis patients. However, we recently reported that serum
TTR levels did not affect protein−energy wasting (PEW). In this study, we investigated factors affecting serum
TTR levels in 60 maintenance hemodialysis patients. The patients were divided into High-TTR and Low-TTR
groups according to themedian serumTTR level. Albumin levels were significantly higher and C-reactive protein
(CRP) levels were significantly lower in the High-TTR group than in the Low-TTR group. Although body fat
mass was significantly higher in the High-TTR group than in the Low-TTR group, no significant difference in
body fat ratio were observed. These findings suggest that body fat mass is related to serum TTR levels, apart from
factors such as albumin and CRP levels, which showed correlations with serum TTR levels. Because body fat
mass is related to better survival in maintenance hemodialysis patients, it may contribute to the prognostic
value of serumTTR levels. In addition, in such patients, it may be important to evaluate body fat mass rather than
body fat ratio and to maintain the minimum necessary body fat mass. J. Med. Invest. 64 : 222-227, August, 2017
Keywords : bioelectrical impedance analysis, nutrition, prealbumin, protein-energy wasting
Received for publication March 26, 2017 ; accepted April 30, 2017.
Address correspondence and reprint requests to Department of Thera-
peutic Nutrition, Institute of Biomedical Sciences, Tokushima University
Graduate School, 3 -18 -15 Kuramoto-Cho, Tokushima 770-8503, Japan
and Fax : +81-88 -633-9574.
The Journal of Medical Investigation Vol. 64 2017
222
Anthropometricmeasurements
Patient’s height data were obtained from their clinical records.
Body weights in this study refer to dry weight defined as post-
dialysis weight in patients without edema. Body mass index (BMI)
was calculated as dry weight (kg) divided by the square of height
(m2) and expressed in kg/m2.
Serumchemistry
Blood samples were obtained at the first dialysis session of May
2012. All assays were performed in the hospital laboratory using
routine methods. Complete blood counts were measured using a
ADVIA2120 hematology analyzer (Siemens, Munich, Germany).
Biochemical parameters were measured using a Hitachi 7600-020
automatic biochemical analyzer (Hitachi Ltd., Tokyo, Japan). Nor-
malized protein catabolic rate (nPCR) (g/kg/day), which is known
to be a valid surrogate for dietary protein intake, was measured
using kinetic modeling. Urea clearance (Kt/V) was used for evalu-
ation of the adequacy of dialysis.
Body composition measurements by bioelectrical impedance
analysis (BIA)
BIA is a noninvasive and widely used method for measuring
body composition. In this study, body composition was measured
using Inbody S20 (Inbody Japan Inc., Tokyo, Japan)after dialysis.
Inbody S20 is a multifrequency analyzer that uses an eight-polar
tactile electrode system.
Survey of dietary intake and physical activity
Survey of dietary intake was performed in individual interviews
by dietitian using three-day dietary records self -reported by the
patients. The patients did not have dietary restrictions and were
asked to follow their usual diet on the day before the date of meas-
urements. Amount of energy and nutrients was calculated by
Excel -Eiyokun software (Kenpakusha Co., Ltd., Tokyo, Japan)
Physical activity was assessed using Lifecorder (Suzuken Co.,
Ltd., Nagoya, Japan). Lifecorder is a commercially available physi-
cal activity monitor based on a uniaxial acceleration sensor.
Statistical analysis
Continuous variables were summarized as meanstandard
deviation, and difference in means was evaluated by Student’s t -
test. Categorical variables were compared among groups by chi -
square test. P values of0.05 were accepted as statistically signifi-
cant. All statistical analyses were performed by JMP version 10
(SAS Institute, Cary, NC, USA).
RESULTS
Characteristics of the study population
The characteristics of study population are listed in Table 1.
Subjects consisted of 60 maintenance hemodialysis patients with
meanage of 66.29.5 years, and 73% patients were male (n = 44).
The mean duration of hemodialysis was 12.38.5 years. Clinical
diagnosis of end-stage renal failure was primary renal disease
(60%, n = 36) and diabetic nephropathy (40%, n = 24). Ten patients
(16%) were diagnosed with PEW according to the ISRNM diag-
nostic criteria.
Variability of serum TTR level
Figure 1 shows the variability of serum TTR levels. The mean,
median, and range of serum TTR levels were 24.86.9 mg/dL,
25.5 mg/dL (interquartile range : 20.530.2 mg/dL) and 6.541.1
mg/dL, respectively. Serum TTR levels did not differ by age, gen-
der, hemodialysis duration, or diabetes status. However, serum
TTR levels were positively correlated with serum albumin levels
(r = 0.57, P0.0001) and were negatively correlated with C-reactive
protein (CRP) levels (r=0.49, P0.0001).
To investigate factors affecting serum TTR levels, patients were
divided into the following two groups at the median serum TTR
level : High-TTR group and Low-TTR group.
Difference of characteristics between High-TTR and Low-TTR
groups
The demographic, clinical, and anthropometric characteristics
of the High-TTR and Low-TTR groups are shown in Table 2. Mean
age, gender, hemodialysis duration, diabetes status, PEW status,
and BMI were not significantly different between the groups.
Table1. Characteristics of the study population
n=60
Age(years) 66.29.5
Gender(men/women) 44/16
Hemodialysis duration(years) 12.38.5
Diabetes(diabetes/non-diabetes) 24/36
PEW(PEW/non-PEW) 10/50
Height(cm) 159.88.9
Body weight(kg) 53.311.0
Body mass index(kg/m2) 20.73.1
Skeletal muscle ratio (%) 40.35.4
Body fat ratio (%) 24.09.5
Kt/V 1.440.23
PEW : protein -energy wasting
Kt/V : urea clearance
Fig.1. Variability of serum TTR level
Box plots showing the variability of serum TTR levels in all patients (n =
60). The maximum serum TTR level was 41.1 mg/dL and the minimum
was 6.5 mg/dL. The box represents the interquartile range. The upper
line represents the upper quartile (75th percentile) and the lower line
represents the lower quartile (25th percentile), which were 30.2 mg/dL
and 20.5 mg/dL, respectively. The median serum TTR is represented by
the line within the box and was 25.5 mg/dL.
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However, body weight was significantly higher in the High-TTR
group than in the Low-TTR group.
The biochemical characteristics are summarized in Table 3. Se-
rum TTR levels in the High-TTR and Low-TTR groups were 30.5
3.3 mg/dL and 19.24.5 mg/dL, respectively. Albumin, blood
urea nitrogen, creatinine levels, and nPCR were significantly higher
and CRP levels were significantly lower in the High-TTR group
than in the Low-TTR group.
Table 4 shows the body composition data. Body fat mass was
significantly higher in the High-TTR group than in the Low-TTR
group. Dietary intake and physical activity were not different be-
tween the High-TTR and Low-TTR groups, as shown in Table 5.
Table 2. Difference of demographic, clinical, and anthropometric characteristics between High-TTR and
Low-TTR groups
High-TTR
(n=30)
Low-TTR
(n=30) P value
Age(years) 65.26.9 67.211.5 0.42
Gender(men/women) 23/7 21/9 0.56
Hemodialysis duration(years) 11.77.2 13.09.7 0.55
Diabetes(diabetes/non-diabetes) 12/18 12/18 1.00
PEW(PEW/non-PEW) 3/27 7/23 0.17
Height(cm) 162.09.7 157.77.5 0.06
Body weight(kg) 56.512.4 50.18.5 0.05
Body mass index(kg/m2) 21.43.2 20.02.8 0.10
PEW : protein -energy wasting
Table3. Difference of biochemical characteristics between High-TTR and Low-TTR groups
High-TTR
(n=30)
Low-TTR
(n=30) P value
Total protein(g/dL) 6.60.4 6.50.6 0.51
Albumin(g/dL) 3.90.3 3.60.4 0.01
Transthyretin(mg/dL) 30.53.3 19.24.5 0.01
Total cholesterol (mg/dL) 150.128.6 136.735.0 0.12
Aspartate aminotransferase(IU/L) 13.16.0 15.85.5 0.07
Alanine aminotransferase(IU/L) 10.54.0 11.67.4 0.48
Alkaline phosphatase(IU/L) 227.477.3 263.4136.9 0.22
Lactate dehydrogenase(IU/L) 205.452.2 194.231.7 0.32
Creatine phosphokinase(IU/L) 124.872.6 99.286.8 0.22
Blood urea nitrogen(mg/dL) 67.015.1 57.313.2 0.01
Creatinine(mg/dL) 12.22.4 10.53.1 0.05
Sodium(mEq/L) 140.62.4 139.73.1 0.23
Potassium(mEq/L) 4.90.5 4.60.8 0.11
Chloride(mEq/L) 103.92.9 103.43.3 0.49
Calcium(mEq/L) 9.30.6 9.20.5 0.75
Phosphate(mEq/L) 5.81.1 5.61.3 0.49
Magnesium(mg/dL) 2.30.3 2.20.3 0.05
Glucose(mg/dL) 139.448.2 134.334.4 0.64
C-reactive protein(mg/dL) 0.180.24 0.761.31 0.05
Iron(µg/dL) 58.523.4 49.819.6 0.12
Total iron binding capacity (µg/dL) 276.550.5 262.457.8 0.32
Ferritin(ng/mL) 115.7233.4 90.2101.9 0.58
Intact parathyroid hormone(pg/mL) 148.281.7 159.8109.1 0.64
nPCR(g/kg/day) 0.850.15 0.760.13 0.05
Kt/V 1.430.23 1.450.23 0.76
nPCR : normalized protein catabolic rate
Kt/V : urea clearance
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DISCUSSION
Although serum TTR levels have been reported to be a reliable
nutritional indicator and independent prognostic factor for mainte-
nance hemodialysis patients (3, 10, 13, 14), we recently suggested
that serum TTR levels did not affect PEW or malnutrition status
(15). Therefore, we speculated that factors other than the nutri-
tional status influence the correlation between serum TTR levels
and survival. In this study, we divided 60 Japanese maintenance
hemodialysis patients into two groups according to the median
serum TTR level and investigated factors affecting serum TTR lev-
els. The results suggest that body fat mass is related to serum
TTR levels, apart from factors such as albumin and CRP levels,
which showed correlations withserum TTR levels.
TTR is a 5.5-kDa homotetrameric protein mainly synthesized in
the liver ; it has a rapid turnover rate, shorthalf - life (1.9 days), high
tryptophan content, and small pool size (16). TTR is reported to
correlate well with albumin and CRP, because its synthesis in the
liver decreases in inflammatory states (10, 12, 14). In this study,
serum TTR levels were positively correlated with serum albumin
levels and were negatively correlated with serum CRP levels,
which is consistent with the findings of previous studies.
The main function of TTR is to transport the thyroid hormone
thyroxine and retinol (vitamin A) (10). TTR binds thyroxinedi-
rectly and transports it to target cells. On the other hand, retinol is
transported indirectly through retinol -binding protein 4 (RBP4).
TTR transports retinol to target cells by binding to retinolRBP4
complex. RBP4 is 21-kDa protein mainly synthesized in adipo-
cytes. Considering that RBP4 has a lower molecular weight than
albumin and is filtered in the glomeruli, serum RBP4 levels in-
crease as renal function decreases (17). Noel et al. showed that
serum RPB4 levels were approximately three times higher in
hemodialysis patients than in healthy controls (18). They also
found increased total TTR levels and RBP4-bound TTR levels and
decreased free TTR levels in hemodialysis patients than in the con-
trol group. The decrease in free TTR levels indicates the reduc-
tion in TTR catabolism. Thus, they concluded that combination of
increased serum RBP4 levels, increased of RBP4-bound TTR lev-
els, and decreased free TTR levels is related to elevated serum TTR
levels in dialysis patients. Recently, Alessio et al. reported that
there is a strong positive association between serum RBP4 levels
and body fat mass, especially the visceral fat mass, in maintenance
hemodialysis patients (19). As described above, the relationship
between RBP4 and TTR and that between RBP4 and body fat mass
has been studied. These previous studies may explain the signifi-
cantly higher body fat mass of the High-TTR group than that in the
Low-TTR group. That is, RBP4 may contribute to the relationship
between TTR and body fat mass. In dialysis patients with high body
fat mass, serum TTR levels are considered to be increased beyond
the typical increase seen in general dialysis patients because of the
increased RBP4 production in adipocytes. However, it is unknown
whether serum RBP4 levels were higher in the High-TTR group
than in the Low-TTR group because serum RBP4 levels were not
measured in this study.
In maintenance hemodialysis patients, mortality risk factors es-
tablished in the general population, such as overweight (BMI25
kg/m2) and hypercholesterolemia, are related to better survival.
This paradoxical phenomenon is referred to as ‘‘reverse epidemiol-
ogy’’ (20). The relationship between body fat mass and mortality is
an example of reverse epidemiology. Kakiya et al. measured body
Table4. Difference of body composition data between High-TTR and Low-TTR groups
High-TTR
(n=30)
Low-TTR
(n=30) P value
Intracellular water (L) 18.63.5 17.12.7 0.07
Extracellular water (L) 12.02.1 11.51.6 0.36
Protein(kg) 8.01.5 7.41.2 0.07
Mineral (kg) 2.80.5 2.60.3 0.20
Skeletal muscle mass(kg) 22.34.6 20.33.5 0.07
Skeletal muscle ratio (%) 39.85.2 40.85.6 0.45
Body fat mass(kg) 15.27.5 11.56.1 0.05
Body fat ratio (%) 25.98.8 22.19.9 0.12
Body cell mass(kg) 26.65.0 24.53.9 0.07
Table5. Difference of dietary intake and physical activity between High-TTR and Low-TTR groups
High-TTR
(n=30)
Low-TTR
(n=30) P value
Dietary intake
Energy/body weight(kcal/kg) 33.18.4 32.65.2 0.79
Protein/body weight(g/kg) 1.10.3 1.20.3 0.33
Salt (g) 6.51.4 7.11.8 0.13
Physical activity
Number of steps on the days of
37973175 39152936 0.91
hemodialysis session(steps/day)
Number of steps on the other days of
59204225 60006418 0.96
hemodialysis session(steps/day)
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fat mass of 808 Japanese maintenance hemodialysis patients using
dual -energy X-ray absorptiometry and revealed that higher fat
mass index (kg/m2) was related to lower mortality risk, especially
noncardiovascular disease mortality (21). Noori et al. and Hu-
ang et al. reported similar results (22, 23). They evaluated body
fat mass measured by near- infrared interactance and triceps skin-
fold thickness, respectively. Furthermore, Kalantar -Zadeh et al.
showed that not only a low baseline body fat mass but also fat loss
over time was associated with higher mortality (24). The results of
these studies, including the Japanese study, consistently show that
body fat mass confers a survival advantage in maintenance hemo-
dialysis patients. In this study, body fat mass was related to serum
TTR levels. Therefore, the survival advantage of body fat mass may
contribute to the prognostic value of serum TTR levels in mainte-
nance hemodialysis patients.
Although the mechanisms by which body fat confers a survival
advantage to maintenance hemodialysis patients are unclear, we
speculate that the characteristic functions of adipose tissue may
play a protective role. One of these functions is energy storage.
Maintenance hemodialysis patients are in a sustained inflamma-
tory state as a result of dialysis treatment, and they are exposed to
chronic catabolic stress. When a patient is ill, such as infection,
energy consumption increases as part of the recovery process.
Because fat is a more efficient energy source than carbohydrate
and protein, higher body fat mass permits more energy storage in
the body. Therefore, maintenance hemodialysis patients with high
fat mass seem to have a better chance to survive. Another charac-
teristic function is adipocytokine secretion. Adipose tissue se-
cretes both proinflammatory and anti -proinflammatory cytokines.
Proinflammatory cytokines include interleukin-6 (IL-6) andtumor
necrosis factor -α (TNF-α), and anti -proinflammatory cytokines
include adiponectin. In the general population, increases in body
fat mass causes increases in proinflammatory cytokine levels and
decreases in anti -proinflammatory cytokine levels. However, in
maintenance hemodialysis patients, it is reported that there is no
difference in proinflammatory cytokines based on body fat mass,
and the inverse relationship between body fat mass and plasma
adiponectin levels are no longer significant (21, 24, 25). Such
changes in adipocytokine profile may be related to survival advan-
tage in maintenance hemodialysis patients. Zoccali et al. showed
that maintenance hemodialysis patients have plasma adiponectin
levels that are two to three times higher than the healthy popula-
tion, and increased plasma adiponectin levels were a significant
inverse predictor of cardiovascular disease outcomes (26). Adi-
ponectin is an adipocytokine that protects against atherosclerosis
and insulin resistance. Thus, an increase in plasma adiponectin
levels appears to play important role in better outcomes for mainte-
nance hemodialysis patients. However, it was recently reported by
Rhee et al. that higher adiponectin levels are associated with a
threefold higher all -cause mortality risk (27). These two findings
suggest that although an increase in adiponectin levels has a
beneficial effect formaintenance hemodialysis patients, the effects
are limited only to cardiovascular system. Further studies are
needed to explain the mechanisms by which body fat confers a
survival advantage for maintenance hemodialysis patients.
Finally, in this study, a significant difference in body fat mass was
observed between the High-TTR and Low-TTR groups, whereas
no significant difference in body fat ratio was confirmed. Because
body fat ratio (%) is the ratio of body fat mass to body weight,
patients with the same body fat ratio but different body weights
have different body fat mass (kg). Therefore, it is considered im-
portant to evaluate body fat mass rather than body fat ratio and to
maintain the minimum necessary body fat mass in maintenance
hemodialysis patients.
The present study has some limitations. First, the present study’s
findings are limited the observational design ; that is, the associa-
tion can be established but causality cannot be concluded. Inter-
vention studies are needed to demonstrate causality between
serum TTR levels and body fat mass. Second, the sample size was
small. Although all patients in the dialysis facility were enrolled,
patient number was limited because of the use of a single facility.
Third, the influences of confounding factors were not excluded. In
this study, mean age, gender, and diabetes status were not signifi-
cantly different between the High-TTR and Low-TTR groups ;
however, several studies have reported that these factors affect se-
rum TTR level (3, 14, 28). In addition, nPCR, which is known to be a
valid surrogate for dietary protein intake, was significantly differ-
ent between the High-TTR and Low-TTR groups. On the other
hand, protein intake of dietary record was not significant difference
between these two groups. The reason for the different findings re-
mains unclear. Thus, to confirm whether the association between
serum TTR levels and body fat mass is independent, it is neces-
sary to evaluate more patients and to perform multivariate analy-
ses.
In conclusion, this study showed that body fat mass was corre-
lated with serum TTR levels in maintenance hemodialysis patients.
Because body fat mass is related to better survival in maintenance
hemodialysis patients, body fat mass may contribute to the prog-
nostic value of serum TTR levels. The results of this study may be
important for improving the prognosis of maintenance hemodialysis
patients, although this needs to be confirmed by further study.
CONFLICT OF INTEREST STATEMENT
None declared.
DISCLOSURE OF GRANTS OR OTHER FUNDING
No grant or other funding.
ACKNOWLEDGMENTS
The authors gratefully acknowledge the support of the medical
staff at Iga City General Hospital (Mie, Japan) in collecting clinical
data.
REFERENCES
1. Kalantar -Zadeh K, Kopple JD, Block G, Humphreys MH :
Association among SF36 quality of life measures and nutrition,
hospitalization, and mortality in hemodialysis. J Am Soc
Nephrol 12 : 2797-2806, 2001
2. Kalantar -Zadeh K, Kopple JD, Block G, Humphreys MH : A
malnutrition - inflammation score is correlated with morbidity
and mortality in maintenance hemodialysis patients. Am J
Kidney Dis38 : 1251-1263, 2001
3. Sreedhara R, Avram MM, Blanco M, Batish R, Avram MM,
Mittman N : Prealbumin is the best nutritional predictor of
survival in hemodialysis and peritoneal dialysis. Am J Kidney
Dis 28 : 937-942, 1996
4. Ishimura E, Okuno S, Marukawa T, Katoh Y, Hiranaka T,
Yamakawa T, Morii H, Kim M, Matsumoto N, Shoji T, Inaba
M, Nakatani T, Nishizawa Y : Body fat mass in hemodialysis
patients. Am J Kidney Dis 41 : S137-141, 2003
5. Kopple JD : McCollum Award Lecture, 1996 : protein-energy
malnutrition in maintenance dialysis patients. Am J Clin Nutr
65 : 1544 -1557, 1997
6. Kalantar -Zadeh K, Ikizler TA, Block G, Avram MM, Kopple
226 S. Matsuura, et al. Body fat and serum TTR in HD patients
JD : Malnutrition- inflammation complex syndrome in dialysis
patients : causes and consequences. Am J Kidney Dis 42 : 864-
881, 2003
7. Fouque D, Kalantar -Zadeh K, Kopple J, Cano N, Chauveau P,
Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G,
Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P,
Treviño-Becerra A, Wanner C : A proposed nomenclature
and diagnostic criteria for protein-energy wasting in acute and
chronic kidney disease. Kidney Int 73 : 391-398, 2008
8. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar -
Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner C, Wang AY,
ter Wee P, Franch HA : Etiology of the protein-energy wast-
ing syndrome in chronic kidney disease : a consensus state-
ment from the International Society of Renal Nutrition and
Metabolism (ISRNM). J Ren Nutr 23 : 77-90, 2013
9. Measurement of visceral protein status in assessing protein
and energy malnutrition : standard of care. Prealbumin in
Nutritional Care Consensus Group. Nutrition 11 : 169-171,
1995
10. Chertow GM, Ackert K, Lew NL, Lazarus JM, Lowrie EG :
Prealbumin is as important as albumin in the nutritional as-
sessment of hemodialysis patients. Kidney Int 58 : 2512-2517,
2000
11. Duggan A, Huffman FG : Validation of serum transthyretin
(prealbumin) as a nutritional parameter in hemodialysis pa-
tients. J Ren Nutr 8 : 142-149, 1998
12. Sathishbabu M, Suresh S : A study on correlation of serum
prealbumin with other biochemical parameters of malnutri-
tion in hemodialysis patient. Int J Biol Med Res 3 : 1410-1412,
2012
13. Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar -Zadeh
K : Association of serum prealbumin and its changes over
time with clinical outcomes and survival in patients receiving
hemodialysis. Am J Clin Nutr 88 : 1485-1494, 2008
14. Mittman N, Avram MM, Oo KK, Chattopadhyay J : Serum
prealbumin predicts survival in hemodialysis and peritoneal
dialysis : 10 years of prospective observation. Am J Kidney Dis
38 : 1358-1364, 2001
15. Yasui S, Shirai Y, Tanimura M, Matsuura S, Saito Y, Miyata K,
Ishikawa E, Miki C, Hamada Y : Prevalence of protein-energy
wasting (PEW) and evaluation of diagnostic criteria in Japanese
maintenance hemodialysis patients. Asia Pac J Clin Nutr 25 :
292-299, 2016
16. Ingenbleek Y, De Visscher M, De Nayer P : Measurement of
prealbumin as index of protein-calorie malnutrition. Lancet 2 :
106 -109, 1972
17. Henze A, Frey SK, Raila J, Tepel M, Scholze A, Pfeiffer AF,
Weickert MO, Spranger J, Schweigert FJ : Evidence that
kidney function but not type 2 diabetes determines retinol -
binding protein 4 serum levels. Diabetes 57 : 3323-3326, 2008
18. Cano N, Di Costanzo-Dufetel J, Calaf R, Durbec JP, Lacombe P,
Pascal S, Stroumza P, Labastie -Coeyrehourcq J : Prealbumin-
retinol -binding-protein-retinol complex in hemodialysis pa-
tients. Am J Clin Nutr 47 : 664-667, 1988
19. Molfino A, Heymsfield SB, Zhu F, Kotanko P, Levin NW,
Dwyer T, Kaysen GA : Prealbumin is associated with visceral
fat mass in patients receiving hemodialysis. J Ren Nutr 23 :
406-410, 2013
20. Kalantar -Zadeh K, Block G, Humphreys MH, Kopple JD :
Reverse epidemiology of cardiovascular risk factors in mainte-
nance dialysis patients. Kidney Int 63 : 793-808, 2003
21. Kakiya R, Shoji T, Tsujimoto Y, Tatsumi N, Hatsuda S,
Shinohara K, Kimoto E, Tahara H, Koyama H, Emoto M,
Ishimura E, Miki T, Tabata T, Nishizawa Y : Body fat mass and
lean mass as predictors of survival in hemodialysis patients.
Kidney Int 70 : 549-556, 2006
22. Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R,
Oreopoulos A, Luna A, Benner D, Kopple JD, Kalantar -Zadeh
K : Survival predictability of lean and fat mass in men and
women undergoing maintenance hemodialysis. Am J Clin
Nutr 92 : 1060-1070, 2010
23. Huang CX, Tighiouart H, Beddhu S, Cheung AK, Dwyer JT,
Eknoyan G, Beck GJ, Levey AS, Sarnak MJ : Both low muscle
mass and low fat are associated with higher all -cause mor-
tality in hemodialysis patients. Kidney Int 77 : 624-629, 2010
24. Kalantar -Zadeh K, Kuwae N, WuDY, Shantouf RS, Fouque D,
Anker SD, Block G, Kopple JD : Associations of body fat and
its changes over time with quality of life and prospective
mortality in hemodialysis patients. Am J Clin Nutr 83 : 202-
210, 2006
25. Shoji T, Shinohara K, Hatsuda S, Kimoto E, Fukumoto S,
Emoto M, TaharaH,Koyama H, Ishimura E, Miki T, Tabata T,
Nishizawa Y : Altered relationship between body fat and
plasma adiponectin in end-stage renal disease. Metabolism
54 : 330-334, 2005
26. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S,
Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda
F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N,
Kihara S, Funahashi T, Matsuzawa Y : Adiponectin, meta-
bolic risk factors, and cardiovascular events among patients
with end-stage renal disease. J Am Soc Nephrol 13 : 134-141,
2002
27. Rhee CM, Nguyen DV, Moradi H, Brunelli SM, Dukipati R,
Jing J, Nakata T, Kovesdy CP, Brent GA, Kalantar -Zadeh K :
Association of Adiponectin with Body Composition and Mor-
tality in Hemodialysis Patients. Am J Kidney Dis 66 : 313-
321, 2015
28. Dalrymple LS, Johansen KL, Chertow GM, Grimes B, Anand
S, McCulloch CE, Kaysen GA : Longitudinal measures of se-
rum albumin and prealbumin concentrations in incident dialy-
sis patients : the comprehensive dialysis study. J Ren Nutr 23 :
91-97, 2013
The Journal of Medical Investigation Vol. 64 August 2017 227
